Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Bio-Techne
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
liquid biopsy
exosome-based diagnostics |
| gptkbp:foundedYear |
2008
|
| gptkbp:founder |
gptkb:James_McCullough
|
| gptkbp:headquartersLocation |
gptkb:Waltham,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Exosome Diagnostics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:offersService |
non-invasive cancer diagnostics
|
| gptkbp:parentCompany |
gptkb:Bio-Techne
|
| gptkbp:product |
gptkb:ExoDx_Prostate(IntelliScore)
|
| gptkbp:specializesIn |
RNA and protein analysis from exosomes
|
| gptkbp:website |
https://www.exosomedx.com/
|
| gptkbp:bfsParent |
gptkb:Bio-Techne_Corporation
gptkb:Bio-Techne |
| gptkbp:bfsLayer |
7
|